119 related articles for article (PubMed ID: 17640541)
1. The use of biomarkers for the evaluation and treatment of patients with acute coronary syndromes.
Saenger AK; Jaffe AS
Med Clin North Am; 2007 Jul; 91(4):657-81; xi. PubMed ID: 17640541
[TBL] [Abstract][Full Text] [Related]
2. Elevated placental growth factor levels are associated with adverse outcomes at four-year follow-up in patients with acute coronary syndromes.
Lenderink T; Heeschen C; Fichtlscherer S; Dimmeler S; Hamm CW; Zeiher AM; Simoons ML; Boersma E;
J Am Coll Cardiol; 2006 Jan; 47(2):307-11. PubMed ID: 16412852
[TBL] [Abstract][Full Text] [Related]
3. Using biomarkers to assess risk and consider treatment strategies in non-ST-segment elevation acute coronary syndromes.
Amos A; Newby LK
Curr Cardiol Rep; 2005 Jul; 7(4):263-9. PubMed ID: 15987623
[TBL] [Abstract][Full Text] [Related]
4. Markers of acute coronary syndrome in emergency room.
Loria V; Dato I; De Maria GL; Biasucci LM
Minerva Med; 2008 Oct; 99(5):497-517. PubMed ID: 18971915
[TBL] [Abstract][Full Text] [Related]
5. [Multi-biomarker approach to acute coronary syndrome].
Seino Y; Ogawa A; Yamashita T; Fujita N; Ogata K
Nihon Rinsho; 2006 Apr; 64(4):691-9. PubMed ID: 16613186
[TBL] [Abstract][Full Text] [Related]
6. Investigation of a multimarker approach to the initial assessment of patients with acute chest pain.
McCann CJ; Glover BM; Menown IB; Moore MJ; McEneny J; Owens CG; Smith B; Sharpe PC; Young IS; Adgey JA
Adv Ther; 2009 May; 26(5):531-4. PubMed ID: 19475367
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the multiple-biomarker approach for diagnosis of myocardial infarction in patients presenting with symptoms suggestive of acute coronary syndrome.
Apple FS; Smith SW; Pearce LA; Murakami MM
Clin Chem; 2009 Jan; 55(1):93-100. PubMed ID: 19028826
[TBL] [Abstract][Full Text] [Related]
8. The impact of B-type natriuretic peptide in addition to troponin I, creatine kinase-MB, and myoglobin on the risk stratification of emergency department chest pain patients with potential acute coronary syndrome.
Brown AM; Sease KL; Robey JL; Shofer FS; Hollander JE
Ann Emerg Med; 2007 Feb; 49(2):153-63. PubMed ID: 17084941
[TBL] [Abstract][Full Text] [Related]
9. The value of bedside cardiac multibiomarker assay in rapid and accurate diagnosis of acute coronary syndromes.
Dadkhah S; Sharain K; Sharain R; Kiabayan H; Foschi A; Zonia C; Huettl B; French S; Gray E; Venkatachalam S; Hegazy H; Aldinger G
Crit Pathw Cardiol; 2007 Jun; 6(2):76-84. PubMed ID: 17667870
[TBL] [Abstract][Full Text] [Related]
10. Use of biomarkers in the emergency department and chest pain unit.
Jaffe AS
Cardiol Clin; 2005 Nov; 23(4):453-65, vi. PubMed ID: 16278117
[TBL] [Abstract][Full Text] [Related]
11. Myocardial injury in coronary artery bypass grafting: on-pump versus off-pump comparison by measuring high-sensitivity C-reactive protein, cardiac troponin I, heart-type fatty acid-binding protein, creatine kinase-MB, and myoglobin release.
Chowdhury UK; Malik V; Yadav R; Seth S; Ramakrishnan L; Kalaivani M; Reddy SM; Subramaniam GK; Govindappa R; Kakani M
J Thorac Cardiovasc Surg; 2008 May; 135(5):1110-9, 1119.e1-10. PubMed ID: 18455592
[TBL] [Abstract][Full Text] [Related]
12. Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18.
Morrow DA; Sabatine MS; Brennan ML; de Lemos JA; Murphy SA; Ruff CT; Rifai N; Cannon CP; Hazen SL
Eur Heart J; 2008 May; 29(9):1096-102. PubMed ID: 18339606
[TBL] [Abstract][Full Text] [Related]
13. Newer cardiac biomarkers in myocardial necrosis.
Sachdeva A; Paul B
J Assoc Physicians India; 2014 Oct; 62(10):83-4. PubMed ID: 25906536
[No Abstract] [Full Text] [Related]
14. Potential clinical application of novel cardiac biomarkers for acute myocardial infarction.
Nursalim A; Suryaatmadja M; Panggabean M
Acta Med Indones; 2013 Jul; 45(3):240-50. PubMed ID: 24045397
[TBL] [Abstract][Full Text] [Related]
15. Individualizing therapy in acute coronary syndromes: using a multiple biomarker approach for diagnosis, risk stratification, and guidance of therapy.
Mo VY; De Lemos JA
Curr Cardiol Rep; 2004 Jul; 6(4):273-8. PubMed ID: 15182604
[TBL] [Abstract][Full Text] [Related]
16. Heart-type fatty acid binding protein--a reliable marker of myocardial necrosis in a heterogeneous group of patients with acute coronary syndrome without persistent ST elevation.
Figiel Ł; Kasprzak JD; Peruga J; Lipiec P; Drozdz J; Krzemińska-Pakuła M; Smigielski J
Kardiol Pol; 2008 Mar; 66(3):253-9, discussion 260-1. PubMed ID: 18393112
[TBL] [Abstract][Full Text] [Related]
17. Heart-type, fatty-acid binding protein can be a diagnostic marker in acute coronary syndromes.
Cavus U; Coskun F; Yavuz B; Ciftci O; Sahiner L; Aksoy H; Deniz A; Ozakin E; Aytemir K; Tokgozoglu L; Kabakci G
J Natl Med Assoc; 2006 Jul; 98(7):1067-70. PubMed ID: 16895274
[TBL] [Abstract][Full Text] [Related]
18. [Leading symptoms of chest pain in the emergency room. Using cardiac markers for risk stratification].
Walter S; Carlsson J; Cuneo A; Tebbe U
Dtsch Med Wochenschr; 2001 Jul; 126(27):771-8. PubMed ID: 11486476
[TBL] [Abstract][Full Text] [Related]
19. Markers of myocardial injury and dysfunction.
Casey PE
AACN Clin Issues; 2004; 15(4):547-57. PubMed ID: 15586156
[TBL] [Abstract][Full Text] [Related]
20. Pregnancy-associated plasma protein A as a marker of acute coronary syndromes.
Bayes-Genis A; Conover CA; Overgaard MT; Bailey KR; Christiansen M; Holmes DR; Virmani R; Oxvig C; Schwartz RS
N Engl J Med; 2001 Oct; 345(14):1022-9. PubMed ID: 11586954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
